ANIX — Anixa Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $112.42m
- $95.66m
- 33
- 13
- 95
- 44
Annual cashflow statement for Anixa Biosciences, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.1 | -13.1 | -13.8 | -9.93 | -12.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.34 | 8.11 | 6.79 | 4.78 | 4.84 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.459 | 0.079 | 0.485 | -1.06 | 0.526 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -6.18 | -4.94 | -6.49 | -6.21 | -7.33 |
| Capital Expenditures | -0.016 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.29 | -3.92 | -10.7 | -5.6 | 4.28 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.306 | -3.92 | -10.7 | -5.6 | 4.28 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 9.41 | 31.6 | 0.452 | 0.366 | 3.42 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.93 | 22.7 | -16.8 | -11.4 | 0.356 |